Company intelligence / Profile preview
Reliance GeneMedix
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
GeneMedix is a biopharmaceutical company specializing in the development and manufacture of biosimilar versions of high-value protein-based drugs. Originally established in the UK, the company focuses on complex biologics including erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), and various monoclonal antibodies. Following its acquisition by Reliance Life Sciences, GeneMedix serves as a key European hub for the group's biosimilar pipeline, leveraging its manufacturing facility in Ireland. The company's business model centers on providing affordable access to life-saving biological therapies across global markets.
- Therapeutic areas
- HematologyOncologyInfectious Diseases
- Modalities
- BiologicMonoclonal antibodyRecombinant protein
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Reliance GeneMedix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reliance GeneMedix.